Skip to main content
Erschienen in: International Journal of Colorectal Disease 4/2016

10.02.2016 | Original Article

Factors associated with the location of local rectal cancer recurrence and predictors of survival

verfasst von: Peng Du, John P. Burke, Wisam Khoury, Ian C. Lavery, Ravi P. Kiran, Feza H. Remzi, David W. Dietz

Erschienen in: International Journal of Colorectal Disease | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The location of locally recurrent rectal cancer (LRRC) may influence survival. This study examines factors affecting the location of LRRC, the effect of LRRC location on survival, and predictive factors for survival in patients with LRRC.

Methods

Patients undergoing initial proctectomy and subsequent management of LRRC at the Cleveland Clinic (1980–2011) were included. Data regarding index surgery, LRRC, and survival were obtained from a prospectively maintained database.

Results

One hundred and fifty-seven patients were identified with a mean follow-up 59.8 ± 50.1 months and time to LRRC of 31.7 ± 30.1 months. Sixty patients underwent surgery with curative intent. Anastomotic leak and retrieving less than 12 lymph nodes at index proctectomy were associated with posterior (P = 0.019) and lateral (P = 0.036) recurrences, respectively. Having an axial relative to an anterior, posterior, or lateral recurrence was associated with improved overall survival (P = 0.001). On multivariable analysis, undergoing primarily palliative treatment (OR, 5.2; 95 % confidence interval (CI), 3.2–8.4; P < 0.001), age at LRRC >60 years (OR, 1.9; 95 % CI, 1.3–2.7, P < 0.001), advanced primary tumour stage (OR, 1.5; 95 % CI, 1.1–2.1; P = 0.021), and anastomotic leak at index surgery (OR, 1.8; 95 % CI, 1.2–2.7; P = 0.008) were associated with reduced LRRC 5-year survival.

Conclusions

The current study suggests that features of the primary tumour and technical factors at the time of index proctectomy influence both the location of LRRC and survival.
Literatur
1.
Zurück zum Zitat Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B (2005) Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 92(2):225–229CrossRefPubMed Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B (2005) Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 92(2):225–229CrossRefPubMed
2.
Zurück zum Zitat Palmer G, Martling A, Cedermark B, Holm T (2007) A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 14(2):447–454CrossRefPubMed Palmer G, Martling A, Cedermark B, Holm T (2007) A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 14(2):447–454CrossRefPubMed
3.
Zurück zum Zitat Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O’Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG et al (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22(10):1785–1796CrossRefPubMed Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O’Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG et al (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22(10):1785–1796CrossRefPubMed
4.
Zurück zum Zitat Gerard JP, Azria D, Gourgou-Bourgade S, Martel-Lafay I, Hennequin C, Etienne PL, Vendrely V, Francois E, de La Roche G, Bouche O et al (2012) Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol 30(36):4558–4565CrossRefPubMed Gerard JP, Azria D, Gourgou-Bourgade S, Martel-Lafay I, Hennequin C, Etienne PL, Vendrely V, Francois E, de La Roche G, Bouche O et al (2012) Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol 30(36):4558–4565CrossRefPubMed
5.
Zurück zum Zitat Sagar PM, Gonsalves S, Heath RM, Phillips N, Chalmers AG (2009) Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 96(2):191–196CrossRefPubMed Sagar PM, Gonsalves S, Heath RM, Phillips N, Chalmers AG (2009) Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 96(2):191–196CrossRefPubMed
6.
Zurück zum Zitat Bosman SJ, Holman FA, Nieuwenhuijzen GA, Martijn H, Creemers GJ, Rutten HJ (2014) Feasibility of reirradiation in the treatment of locally recurrent rectal cancer. Br J Surg 101(10):1280–1289CrossRefPubMed Bosman SJ, Holman FA, Nieuwenhuijzen GA, Martijn H, Creemers GJ, Rutten HJ (2014) Feasibility of reirradiation in the treatment of locally recurrent rectal cancer. Br J Surg 101(10):1280–1289CrossRefPubMed
7.
Zurück zum Zitat Colibaseanu DT, Dozois EJ, Mathis KL, Rose PS, Ugarte ML, Abdelsattar ZM, Williams MD, Larson DW (2014) Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes? Dis Colon Rectum 57(1):47–55CrossRefPubMed Colibaseanu DT, Dozois EJ, Mathis KL, Rose PS, Ugarte ML, Abdelsattar ZM, Williams MD, Larson DW (2014) Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes? Dis Colon Rectum 57(1):47–55CrossRefPubMed
8.
Zurück zum Zitat Beyond TME (2013) Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):1009–1014CrossRef Beyond TME (2013) Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):1009–1014CrossRef
9.
Zurück zum Zitat Harji DP, Sagar PM (2012) Advancing the surgical treatment of locally recurrent rectal cancer. Br J Surg 99(9):1169–1171CrossRefPubMed Harji DP, Sagar PM (2012) Advancing the surgical treatment of locally recurrent rectal cancer. Br J Surg 99(9):1169–1171CrossRefPubMed
10.
Zurück zum Zitat Bhangu A, Ali SM, Darzi A, Brown G, Tekkis P (2012) Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Color Dis 14(12):1457–1466CrossRef Bhangu A, Ali SM, Darzi A, Brown G, Tekkis P (2012) Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Color Dis 14(12):1457–1466CrossRef
11.
Zurück zum Zitat Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC (2001) Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 44(2):173–178CrossRefPubMed Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC (2001) Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 44(2):173–178CrossRefPubMed
12.
Zurück zum Zitat Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M, Paty PB, Wong WD, Guillem JG (2004) Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 47(10):1599–1606CrossRefPubMed Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M, Paty PB, Wong WD, Guillem JG (2004) Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 47(10):1599–1606CrossRefPubMed
13.
Zurück zum Zitat Wanebo HJ, Antoniuk P, Koness RJ, Levy A, Vezeridis M, Cohen SI, Wrobleski DE (1999) Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 42(11):1438–1448CrossRefPubMed Wanebo HJ, Antoniuk P, Koness RJ, Levy A, Vezeridis M, Cohen SI, Wrobleski DE (1999) Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 42(11):1438–1448CrossRefPubMed
14.
Zurück zum Zitat Suzuki K, Dozois RR, Devine RM, Nelson H, Weaver AL, Gunderson LL, Ilstrup DM (1996) Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 39(7):730–736CrossRefPubMed Suzuki K, Dozois RR, Devine RM, Nelson H, Weaver AL, Gunderson LL, Ilstrup DM (1996) Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 39(7):730–736CrossRefPubMed
15.
Zurück zum Zitat Secco GB, Ravera G, Bonfante P, Gianquinto D, Baldi E, Canaletti M, Ferraris R (2001) Prognostic indicators of local recurrence in patients operated for rectal cancer. Hepatogastroenterology 48(41):1346–1350PubMed Secco GB, Ravera G, Bonfante P, Gianquinto D, Baldi E, Canaletti M, Ferraris R (2001) Prognostic indicators of local recurrence in patients operated for rectal cancer. Hepatogastroenterology 48(41):1346–1350PubMed
16.
Zurück zum Zitat Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, Abbott CR, Scott N, Finan PJ, Johnston D et al (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235(4):449–457CrossRefPubMedPubMedCentral Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, Abbott CR, Scott N, Finan PJ, Johnston D et al (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235(4):449–457CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Manfredi S, Benhamiche AM, Meny B, Cheynel N, Rat P, Faivre J (2001) Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Br J Surg 88(9):1221–1227CrossRefPubMed Manfredi S, Benhamiche AM, Meny B, Cheynel N, Rat P, Faivre J (2001) Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Br J Surg 88(9):1221–1227CrossRefPubMed
18.
Zurück zum Zitat Dresen RC, Peters EE, Rutten HJ, Nieuwenhuijzen GA, Demeyere TB, van den Brule AJ, Kessels AG, Beets-Tan RG, van Krieken JH, Nagtegaal ID (2009) Local recurrence in rectal cancer can be predicted by histopathological factors. Eur J Surg Oncol 35(10):1071–1077CrossRefPubMed Dresen RC, Peters EE, Rutten HJ, Nieuwenhuijzen GA, Demeyere TB, van den Brule AJ, Kessels AG, Beets-Tan RG, van Krieken JH, Nagtegaal ID (2009) Local recurrence in rectal cancer can be predicted by histopathological factors. Eur J Surg Oncol 35(10):1071–1077CrossRefPubMed
19.
Zurück zum Zitat Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH (2002) Cooperative Clinical Investigators of the Dutch Colorectal Cancer G: macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20(7):1729–1734CrossRefPubMed Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH (2002) Cooperative Clinical Investigators of the Dutch Colorectal Cancer G: macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20(7):1729–1734CrossRefPubMed
20.
Zurück zum Zitat Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P (2011) Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg 253(5):890–899CrossRefPubMed Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P (2011) Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg 253(5):890–899CrossRefPubMed
21.
Zurück zum Zitat Ashburn JH, Stocchi L, Kiran RP, Dietz DW, Remzi FH (2013) Consequences of anastomotic leak after restorative proctectomy for cancer: effect on long-term function and quality of life. Dis Colon Rectum 56(3):275–280CrossRefPubMed Ashburn JH, Stocchi L, Kiran RP, Dietz DW, Remzi FH (2013) Consequences of anastomotic leak after restorative proctectomy for cancer: effect on long-term function and quality of life. Dis Colon Rectum 56(3):275–280CrossRefPubMed
22.
Zurück zum Zitat Govindarajan A, Gonen M, Weiser MR, Shia J, Temple LK, Guillem JG, Paty PB, Nash GM (2011) Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol 29(34):4568–4573CrossRefPubMedPubMedCentral Govindarajan A, Gonen M, Weiser MR, Shia J, Temple LK, Guillem JG, Paty PB, Nash GM (2011) Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol 29(34):4568–4573CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O’Callaghan C, Myint AS, Bessell E, Thompson LC et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373(9666):821–828CrossRefPubMedPubMedCentral Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O’Callaghan C, Myint AS, Bessell E, Thompson LC et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373(9666):821–828CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Heriot AG, Byrne CM, Lee P, Dobbs B, Tilney H, Solomon MJ, Mackay J, Frizelle F (2008) Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 51(3):284–291CrossRefPubMed Heriot AG, Byrne CM, Lee P, Dobbs B, Tilney H, Solomon MJ, Mackay J, Frizelle F (2008) Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 51(3):284–291CrossRefPubMed
25.
Zurück zum Zitat Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM (1999) Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 6(2):171–177CrossRefPubMed Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM (1999) Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 6(2):171–177CrossRefPubMed
26.
Zurück zum Zitat Bhangu A, Ali SM, Brown G, Nicholls RJ, Tekkis P (2014) Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg 259(2):315–322CrossRefPubMed Bhangu A, Ali SM, Brown G, Nicholls RJ, Tekkis P (2014) Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg 259(2):315–322CrossRefPubMed
27.
Zurück zum Zitat Young JM, Badgery-Parker T, Masya LM, King M, Koh C, Lynch AC, Heriot AG, Solomon MJ (2014) Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. Br J Surg 101(3):277–287CrossRefPubMed Young JM, Badgery-Parker T, Masya LM, King M, Koh C, Lynch AC, Heriot AG, Solomon MJ (2014) Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. Br J Surg 101(3):277–287CrossRefPubMed
28.
Zurück zum Zitat Miner TJ, Jaques DP, Paty PB, Guillem JG, Wong WD (2003) Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol 10(1):72–79CrossRefPubMed Miner TJ, Jaques DP, Paty PB, Guillem JG, Wong WD (2003) Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol 10(1):72–79CrossRefPubMed
29.
Zurück zum Zitat Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC (1987) Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg 205(5):482–495CrossRefPubMedPubMedCentral Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC (1987) Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg 205(5):482–495CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Magrini S, Nelson H, Gunderson LL, Sim FH (1996) Sacropelvic resection and intraoperative electron irradiation in the management of recurrent anorectal cancer. Dis Colon Rectum 39(1):1–9CrossRefPubMed Magrini S, Nelson H, Gunderson LL, Sim FH (1996) Sacropelvic resection and intraoperative electron irradiation in the management of recurrent anorectal cancer. Dis Colon Rectum 39(1):1–9CrossRefPubMed
31.
Zurück zum Zitat Sagar PM (2014) Ultraradical resection for locally recurrent rectal cancer. Dis Colon Rectum 57(1):1–2CrossRefPubMed Sagar PM (2014) Ultraradical resection for locally recurrent rectal cancer. Dis Colon Rectum 57(1):1–2CrossRefPubMed
32.
Zurück zum Zitat Milne T, Solomon MJ, Lee P, Young JM, Stalley P, Harrison JD (2013) Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann Surg 258(6):1007–1013CrossRefPubMed Milne T, Solomon MJ, Lee P, Young JM, Stalley P, Harrison JD (2013) Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann Surg 258(6):1007–1013CrossRefPubMed
33.
Zurück zum Zitat Austin KK, Solomon MJ (2009) Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement. Dis Colon Rectum 52(7):1223–1233CrossRefPubMed Austin KK, Solomon MJ (2009) Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement. Dis Colon Rectum 52(7):1223–1233CrossRefPubMed
34.
Zurück zum Zitat Georgiou PA, Tekkis PP, Brown G (2011) Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options. Cancer Imaging 11(Spec No A):S103–S111CrossRefPubMedPubMedCentral Georgiou PA, Tekkis PP, Brown G (2011) Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options. Cancer Imaging 11(Spec No A):S103–S111CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Guo S, Reddy CA, Kolar M, Woody N, Mahadevan A, Deibel FC, Dietz DW, Remzi FH, Suh JH (2012) Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience. Radiat Oncol 7:110CrossRefPubMedPubMedCentral Guo S, Reddy CA, Kolar M, Woody N, Mahadevan A, Deibel FC, Dietz DW, Remzi FH, Suh JH (2012) Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience. Radiat Oncol 7:110CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Alberda WJ, Verhoef C, Schipper ME, Nuyttens JJ, Rothbarth J, de Wilt JH, Burger JW (2015) The importance of a minimal tumor-free resection margin in locally recurrent rectal cancer. Dis Colon Rectum 58(7):677–685CrossRefPubMed Alberda WJ, Verhoef C, Schipper ME, Nuyttens JJ, Rothbarth J, de Wilt JH, Burger JW (2015) The importance of a minimal tumor-free resection margin in locally recurrent rectal cancer. Dis Colon Rectum 58(7):677–685CrossRefPubMed
Metadaten
Titel
Factors associated with the location of local rectal cancer recurrence and predictors of survival
verfasst von
Peng Du
John P. Burke
Wisam Khoury
Ian C. Lavery
Ravi P. Kiran
Feza H. Remzi
David W. Dietz
Publikationsdatum
10.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 4/2016
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-016-2526-5

Weitere Artikel der Ausgabe 4/2016

International Journal of Colorectal Disease 4/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.